US FDA to provide greater flexibility for new animal drug applications
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued a direct final rule that will require sponsors to submit varying – rather than uniform – information with new animal drug applications, as deemed appropriate for the particular submission1. The rule comes into force on 8 March 2010.